E
Empatica
Designs and develops AI systems to monitor human health through wearable sensors
About Empatica
Empatica specializes in designing and developing AI-enabled wearable devices and software for remote patient monitoring and health research. The company's core products include medical-grade wearables that track physiological and behavioral biomarkers in real-time. These devices are used by distinguished universities, hospitals, companies, and charities to monitor health conditions, forecast potential health issues, and conduct research. Empatica operates in the healthcare technology market, focusing on providing tools that empower patients, clinicians, and researchers with actionable health insights. The business model revolves around selling wearable devices and offering subscription-based software services for continuous health monitoring. Revenue is generated through direct sales of devices and recurring subscription fees for software access.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Milan, Italy
- Employees
- 130
- Open positions
- 1
- Dealroom signal
- 71.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Analytics, Data Analytics, Biotechnology, Core AI, Spinout, AI for medical imaging
- Technology
- Artificial Intelligence, Deep Tech, Connected Device
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Oct 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Aug 2022 | $29M | $114M | RA Capital Management · Sanofi Ventures · Black Opal Ventures | ↗ |
| GRANT✓Other financing | Jun 2020 | $720K | — | HHS Administration for Strategic Preparedness and Response | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Empatica is 65K monthly website visits, down 17.7% over the last three months. Empatica's team declined 0.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
HHS Administration for Strategic Preparedness and Response
Series A6 investors entered at this stage
Innogest Capital
CDP Venture Capital
Endeavor Catalyst
RA Capital Management
Sanofi Ventures
Black Opal Ventures
Other known investors5 additional known investors
Massachusetts Institute of Technology
DRIVe - Division of Research, Innovation, and Ventures
Endeavor
US Biomedical Advanced Research and Development Authority
Vito Lomele
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Empatica on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Empatica’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.